New Developments in the Sackler Case Suggest More Needs to be Done to Hold Pharma Magnates Accountable In the late-1990s and early-2000s, pharmaceutical manufacturers like Purdue Pharma aggressively marketed addictive drugs such as OxyContin, pushing doctors to prescribe them. Today, though it’s known that these companies helped create America’s opioid epidemic, the owners of the… (0 comment)

Awareness of Alcohol Addiction Soars, But Treatment Does Not Even though Americans are aware that alcohol abuse is a problem in the U.S., the treatment gap is wider than ever. Reporting suggests that the gap recently went from 10% of alcohol addicts receiving treatment down to just 6%. What must be done to address this… (0 comment)

Drug Overdose Deaths Jumped Nearly 30 Percent During the Pandemic Many public health experts believed that, partially because of the effects of the COVID-19 pandemic, 2020 was going to be the worst year yet for drug overdoses. They were right, and final numbers for the death toll exceeded even the most gloomy predictions. Read More… (0 comment)

Neonatal Abstinence Syndrome Neonatal abstinence syndrome is a harmful effect of drug addiction. Given the adverse nature of NAS and the many other harmful side effects of substance abuse, women who struggle with drug use should seek help as soon as possible. Read More » Narconon… (0 comment)

If you need prescription medications of any type, there is only one safe way to obtain them: get a prescription from a licensed medical doctor and pick up your pills from a legitimate pharmacy. Any other method such as buying them on the internet, getting them from a friend or obtaining them across the border… (0 comment)

If we knew the consequences of overlooking addiction—and the destruction to individuals, families, businesses, our communities and economy—we might think twice, three times or four times about ignoring it. Indeed, if we really understood how much better our world could be, we might dedicate massive resources to eliminating this social ill. To provide insight into… (0 comment)